Topic · page 20 of 47

Lupus & antiphospholipid syndrome

Systemic and cutaneous lupus erythematosus, lupus nephritis, neuropsychiatric lupus, disease activity, remission and low disease activity, damage, antimalarials and targeted treatment; antiphospholipid antibodies and antiphospholipid syndrome, thrombotic and obstetric

Briefs 761–800 of 1,848 placed here, newest publication first

Briefs in Lupus & antiphospholipid syndrome

Newest publication first

Ann Rheum Dis9 May 2025
Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1
Cross-sectional study
Ann Rheum Dis9 May 2025
Enhanced B cell and complement cascade gene signatures in patients with neuropsychiatric systemic lupus erythematosus
Mechanistic study
Rheumatology (Oxford)8 May 2025
Physical activity in relation to the risk of systemic lupus erythematosus: a prospective study including 401 745 individuals
Cohort study
Semin Arthritis Rheum8 May 2025
Kidney outcomes of systemic lupus erythematosus patients treated with SGLT2 inhibitors: A national cohort study
Cohort study
Arthritis Rheumatol7 May 2025
2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis
Guideline or statement
Arthritis Care Res (Hoboken)7 May 2025
2024 American College of Rheumatology ( ACR ) Guideline for the Screening, Treatment, and Management of Lupus Nephritis
Guideline or statement
Lupus Sci Med6 May 2025
Domains for inclusion in a novel Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE): results of a modified Delphi study
Guideline or statement
Ann Rheum Dis5 May 2025
Janus kinase inhibitors enhance prostanoid biosynthesis in human whole blood in vitro: implications for cardiovascular side effects and prevention strategies
Mechanistic study
Lupus5 May 2025
The effect of belimumab on mucocutaneous and vasculitis manifestations in patients with systemic lupus erythematosus: A large pooled post hoc analysis
Meta-analysis
Clin Exp Rheumatol3 May 2025
Recurrence of thrombosis in patients with primary antiphospholipid syndrome: emphasis on arterial events
Cohort study
Lancet Rheumatol2 May 2025
Long-term effect of anifrolumab on patient-reported outcomes in systemic lupus erythematosus (TULIP-LTE): a randomised, placebo-controlled, phase 3 long-term extension trial
Randomized controlled trial
Arthritis Care Res (Hoboken)2 May 2025
Analysis of the Longitudinal Behavior of Serum Levels of Soluble Flt1 and Placental Growth Factor in Pregnant Patients With Systemic Lupus Erythematosus
Cohort study
Semin Arthritis Rheum1 May 2025
Direct oral anticoagulants versus Vitamin K antagonists in antiphospholipid syndrome: A systematic review and meta-analysis
Meta-analysis
Clin Exp Rheumatol1 May 2025
High sensitivity measurement of circulating interferon proteins in systemic lupus erythematosus
Cross-sectional study
Lancet Rheumatol30 Apr 2025
Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study
Cohort study
Lupus Sci Med29 Apr 2025
Adverse pregnancy outcomes across SLE subgroups: significance of cardiovascular events
Cohort study
Lupus Sci Med28 Apr 2025
Rural–urban disparities in hospitalisation for myocardial infarction in systemic lupus erythematosus in the USA
Cross-sectional study
Lupus Sci Med28 Apr 2025
Can conventional brain MRI support the attribution process in neuropsychiatric SLE? A multicentre retrospective study
Cohort study
Lupus Sci Med28 Apr 2025
Prevalence of sarcopenia and its association with clinical features and health-related quality of life in Brazilian women with systemic lupus erythematosus
Cross-sectional study
Rheumatology (Oxford)25 Apr 2025
Plasma C4d levels correlate with treatment response and renal activity in proliferative lupus nephritis
Cohort study
Arthritis Res Ther25 Apr 2025
Bioinformatic analysis and experimental verification reveal expansion of monocyte subsets with an interferon signature in systemic lupus erythematosus patients
Mechanistic study
Rheumatology (Oxford)24 Apr 2025
Type I interferon dysregulation drives distinct pathogenic pathways in early- and late-onset lupus nephritis
Mechanistic study
RMD Open23 Apr 2025
Outcomes of patients with systemic lupus erythematosus treated with belimumab: a post hoc efficacy analysis of five phase III clinical trials by British Isles Lupus Assessment Group-based Combined Lupus Assessment criteria
Secondary analysis
Lupus Sci Med23 Apr 2025
Proteomics uncovers ICAM2 (CD102) as a novel serum biomarker of proliferative lupus nephritis
Diagnostic or prognostic study
Rheumatology (Oxford)21 Apr 2025
Post-traumatic stress disorder and systemic lupus erythematosus: insights from a systematic review
Meta-analysis
Lupus20 Apr 2025
Association of a self-report screening tool for sarcopenia (SARC-F) with functional status outcomes in systemic lupus erythematosus
Cross-sectional study
Lupus20 Apr 2025
Efficacy and safety of telitacicept in the treatment of systemic lupus erythematosus: A retrospective real-world study
Cohort study
Rheumatology (Oxford)17 Apr 2025
Unsupervised machine learning identifies distinct SLE patient endotypes with differential response to belimumab
Secondary analysis
Lupus14 Apr 2025
Assessment of myocardial dysfunction of patients with systemic lupus erythematosus based on myocardial perfusion imaging and analysis of potential influencing factors
Case-control study
Lupus14 Apr 2025
The role of peritubular capillaritis in severity of lupus nephritis
Cross-sectional study
Lupus Sci Med14 Apr 2025
Clinical and immunological differences between primary and autoimmune-associated neuromyelitis optica spectrum disorders: a retrospective study
Cohort study
Lupus Sci Med14 Apr 2025
Langerhans cells infiltration in lymph nodes of patients with systemic lupus erythematosus
Case-control study
Semin Arthritis Rheum13 Apr 2025
Does the time to the onset of lupus nephritis impact renal disease presentation and outcomes?
Cohort study
Rheumatology (Oxford)12 Apr 2025
Implementation outcomes of a patient decision-aid in a diverse population with systemic lupus erythematosus in 15 US rheumatology clinics
Research article
Rheumatology (Oxford)10 Apr 2025
Histologic predictors of kidney outcomes in LN: re-evaluating the role of segmental glomerulosclerosis in the chronicity index
Cohort study
Rheumatology (Oxford)10 Apr 2025
Temporal trends in glucocorticoids and hydroxychloroquine for treatment of systemic lupus erythematosus in Sweden
Cohort study
Ann Rheum Dis10 Apr 2025
Certolizumab pegol to prevent adverse pregnancy outcomes in patients with antiphospholipid syndrome and lupus anticoagulant (IMPACT): results of a prospective, single-arm, open-label, phase 2 trial
Cohort study
Semin Arthritis Rheum9 Apr 2025
Predicting anxiety and depression in systemic lupus erythematosus: the role of inflammation, sociodemographic variables and clinical factors
Cross-sectional study
RMD Open9 Apr 2025
Prognostic insights from symptom clustering analysis in systemic lupus erythematosus
Cohort study
Rheumatology (Oxford)9 Apr 2025
Vascular liver disorders in patients with antiphospholipid syndrome: a national retrospective multicentre study
Cohort study

All 1,848 Briefs in ExploreShowing Briefs 761–800 of 1,848, newest first